Showing results (81-90 of 326) with videos related to
Sort By:
Pageof 33
Vascular Health and Risk Management|June 16, 2022
Factor XI Inhibition for the Prevention of Venous Thromboembolism: An Update on Current Evidence and Future perspectivesGeraldine Poenou, Teona Dumitru Dumitru, Ludovic Lafaie, et al.Haematologica|December 23, 2003
Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment toolMeyer Michel Samama, Ola E Dahl, Daniel J Quinlan, et al.International Journal of Molecular Sciences|August 7, 2021
Platelet Innate Immune Receptors and TLRs: A Double-Edged SwordThéo Ebermeyer, Fabrice Cognasse, Philippe Berthelot, et al.The Journal of Pharmacology and Experimental Therapeutics|March 25, 2018
In Vitro Assessment of Pharmacokinetic Drug-Drug Interactions of Direct Oral Anticoagulants: Type 5-Phosphodiesterase Inhibitors Are Inhibitors of Rivaroxaban and Apixaban Efflux by P-GlycoproteinVictor Margelidon-Cozzolino, Sophie Hodin, Elodie Jacqueroux, et al.Therapie|June 4, 2011
[Drug induced hyponatremia. About a series of 54 cases notified to the regional center of pharmacovigilance of Saint-Étienne]Ivan Fenoglio, Claire Guy, Marie-Noëlle Beyens, et al.Clinical Pharmacokinetics|January 25, 2006
Compliance-guided therapy : a new insight into the potential role of clinical pharmacologistsAlexia Blesius, Sylvie Chabaud, Michel Cucherat, et al.Journal of the American College of Cardiology|April 12, 2008
SR123781A: a new once-daily synthetic oligosaccharide anticoagulant for thromboprophylaxis after total hip replacement surgery: the DRIVE (Dose Ranging Study in Elective Total Hip Replacement Surgery) studyMichael R Lassen, Ola Dahl, Patrick Mismetti, et al.Fundamental & Clinical Pharmacology|August 15, 2019
In vitro assessment of P-gp and BCRP transporter-mediated drug-drug interactions of riociguat with direct oral anticoagulantsElodie Jacqueroux, Clément Mercier, Victor Margelidon-Cozzolino, et al.Therapie|July 27, 2013
[Intracranial hemorrhages: epidemiology and implication of antithrombotic therapy]Jérôme Varvat, Magali Epinat, Christophe Nuti, et al.Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association|May 13, 2014
Prevention of venous thromboembolic events with low-molecular-weight heparin in the non-major orthopaedic setting: meta-analysis of randomized controlled trialsCéline Chapelle, Nadia Rosencher, Paul Jacques Zufferey, et al.Pageof 33